Latest Top 20 Read Articles

1. Generic portfolio management: A paradigm for minimizing risk and maximizing value

Kinjal Suchak, Lisa J Murray

Journal of Generic Medicines

Vol. 13, No. 2, June 2017, doi:10.1177/1741134316677850

2. EpiPen® Pricing – Evidence of a systemic problem with drug pricing in the USA

Shruti S Costales

Journal of Generic Medicines

Vol. 14, No. 1, March 2018, doi:10.1177/1741134316680391

3. Generic and biosilimilar medicines use and expenditure: A report from the National Observatory on the Use of Medicines (OsMed) of the Italian Medicines Agency (AIFA)

Alessandro Monaco, Federica Mammarella, Agnese Cangini, Roberto Marini, Alessandra Marengoni, Pierluigi Russo, Sergio Pecorelli, Luca Pani

Journal of Generic Medicines

Vol. 12, No. 2, June 2015, doi:10.1177/1741134315618535

4. Compulsory licensing of drug products in developing countries

Satish Saroha, Deepak Kaushik, Arun Nanda

Journal of Generic Medicines

Vol. 12, No. 3-4, September 2015, doi:10.1177/1741134313503827

5. Monopoly and public health in the medication market: The case of sofosbuvir

Paolo Piergentili

Journal of Generic Medicines

Vol. 13, No. 3, September 2017, doi:10.1177/1741134317705691

6. Braintree v. Breckenridge and the potential danger of stipulation to a claim construction from an earlier case

Frederick H Rein, Aviv A Zalcenstein, Kenneth L Mueller

Journal of Generic Medicines

Vol. 14, No. 1, March 2018, doi:10.1177/1741134317739344

7. Amgen v. Sanofi: Can an injunction contrary to the public health interest ever properly be granted?

Frederick Howard Rein, Aviv A. Zalcenstein, Kathleen McGuinness

Journal of Generic Medicines

Vol. 14, No. 2, June 2018, doi:10.1177/1741134318755429

8. A comparison of mechanisms for setting generic drug prices in Canada

Aidan Hollis, Paul Grootendorst

Journal of Generic Medicines

Vol. 13, No. 1, March 2017, doi:10.1177/1741134316669967

9. The Falsified Medicines Directive: How to secure your supply chain

G Smith, JA Smith, DA Brindley

Journal of Generic Medicines

Vol. 11, No. 3-4, September 2014, doi:10.1177/1741134315588986

10. Combatting counterfeit drugs: Case studies of Cambodia, Vietnam and Thailand

Jakkrit Kuanpoth

  Journal of Generic Medicines

  Vol. 14, No. 1, March 2018, doi:10.1177/1741134317728403

11. Compulsory licences on pharmaceutical patents in India: A short article

  Sandeep K. Rathod

  Journal of Generic Medicines

  Vol. 13, No. 3, September 2017, doi:10.1177/1741134317691804

12. The 2011 Canada-European Union Comprehensive Economic and Trade Agreement: an economic impact assessment of the EU’s proposed pharmaceutical intellectual property provisions

  P Grootendorst, A Hollis

  Journal of Generic Medicines

  Vol. 8, No. 2, April 2011, doi:10.1177/1741134311408275

13. Impact of generic entry to off-patent branded medicines in Japanese pharmaceutical market

  Daigo Fukumoto, Takeshi Suzuki

  Journal of Generic Medicines

  Vol. 13, No. 3, September 2017, doi:10.1177/1741134317698194

14. Generic drugs: Current status and future potential

  Neelima Mallam, Chandra Shekar Byalakere Rudraiah, Sushma Rudraswamy

  Journal of Generic Medicines

  Vol. 13, No. 2, June 2017, doi:10.1177/1741134317691803

15. Evaluating patients' perception towards generic and branded medicines: A segmentation approach

  Md Moddassir Alam, Arun Mittal, Deepak Chawla

  Journal of Generic Medicines

  Vol. 13, No. 4, December 2017, doi:10.1177/1741134317737925

16. Physicians’ perceptions towards brand medicine and its effect on prescribing: A narrative review

  Mohsen Ali Murshid, Zurina Mohaidin

  Journal of Generic Medicines

  Vol. 13, No. 4, December 2017, doi:10.1177/1741134317709509

17. Editorial

  Brian W Tempest

  Journal of Generic Medicines

  Vol. 13, No. 3, September 2017, doi:10.1177/1741134317729302

18. TRIPS-Plus Provisions in Trade Agreements and Their Potential Adverse Effects on Public Health

  María Fabiana Jorge

  Journal of Generic Medicines

  Vol. 1, No. 3, April 2004, doi:10.1057/palgrave.jgm.4940023

19. The pharmaceutical market and drug development prognosis in Japan: Current and future perspectives according to pharmacological classes

  Shoyo Shibata, Takeshi Suzuki

  Journal of Generic Medicines

  Vol. 14, No. 2, June 2018, doi:10.1177/1741134317737344

20. Exploring the knowledge and attitude of medical and pharmacy students about generic medicine in Lahore, Pakistan

  Usama Asif, Zikria Saleem, Mahrukh Yousaf, Hamid Saeed, Furqan Khurshid Hashmi, Mohamed Azmi Hassali

  Journal of Generic Medicines

  Vol. 14, No. 1, March 2018, doi:10.1177/1741134317748344